Further backing for HPV (human papillomavirus) screening:
This article was originally published in Clinica
A team of Scandinavian cancer researchers has provided further evidence that screening for human papillomavirus (HPV) in conjunction with cervical Pap smears would improve detection of cervical cancer. There is a growing body of evidence suggesting that persistent HPV infection causes cancer, and the latest study, in the November 25 edition of the New England Journal of Medicine, researchers led Dr Keng-Ling Wallin of the Karolinska Institute in Stockholm found that a single positive finding of HPV DNA in a Pap smear confers an increased risk of cancer that is positive for the same virus.
You may also be interested in...
Senate Finance Committee’s approach to penalize companies for raising WAC list prices is not a ‘price control,’ but a reasonable approach to change the incentives that distort pricing in the supply chain, US HHS Secretary Alex Azar says.
With the pre-GDUFA backlog largely acted upon, the FDA expects ANDA approvals to decrease, but supplement actions to increase in FY 2020 and FY 2021.
February and March inspections deferred unless any are deemed mission critical. China director remains behind as staff evacuate.